Vital Data Observatory Statistics

إحصاءات مرصد المعلومات الحيوية

Statistics List	Date	Description
Live Births by Nationality 2017-2024	27.08.2025	As reported by hospitals to the Vital Data Observatory at MoPH till August 27,2025. Note : Midwifery clinics started reporting to MoPH in 2021.
Number of Non-Lebanese hospital LiveBirths by Qadaa, 2015-2023	16.05.2024	Hospital births by Nationality are reported to the Ministry of Health through the Vital Data Observatory. Since 2021, Midwife-performed births are being reported from Midwifery Clinics and these are around 4,000 so far but can't be segregated by Qada.
Live Births by Nationality 2015-2023	02.05.2024	As reported from hospitals to the Vital Data Observatory at MoPH till 30 April,2024. Midwifery clinics started reporting to the MoPH in 2021.
Vital Data Observatory (VDO) statistics by Qada and nationality, 2018 Download: Table - Dashboard	19.06.2019	Based on data reported to the Ministry of Public Health (MOPH) from hospitals.
Vital Data Observatory (VDO) statistics by Qada and nationality, 2017 Download: Table - Graph - Dashboard	23.02.2018	Based on data reported to the Ministry of Public Health (MOPH) from hospitals.
Vital Data Observatory (VDO) statistics by Qada and nationality, 2016 Download: Table	06.06.2017	Based on data reported to the Ministry of Public Health (MOPH) from hospitals.
Maternal Neonatal Mortality Notification System (MNMNS) statistics by Qada and nationality, 2015 Download: Table	06.06.2017	Based on data reported to the Ministry of Public Health (MOPH) from hospitals.

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L02AE04	GONAPEPTYL	B	Triptorelin acetate - 0.1mg	0.1mg	Injectable solution	4,637,600 L.L
L02AE04	GONAPEPTYL CR	B	Triptorelin - 3.75mg	3.75mg	Injectable powder for suspension+diluent	12,095,730 L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	314,437,416 L.L
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	85,330,070 L.L
L01EB01	GEFITINIB BIOGARAN	G	Gefitinib - 250mg	250mg	Tablet, coated	83,306,550 L.L
L01EB01	GEFITINIB BIOGARAN	G	Gefitinib - 250mg	250mg	Tablet, coated	L.L
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	L.L
L01EA01	GLIMATINIB BENTA 400	G	Imatinib (mesylate) - 400mg	400mg	Tablet, film coated	38,254,090 L.L
L01EA01	GLIVEC	B	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	52,168,478 L.L
L01EA01	GLIMATINIB BENTA	G	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	17,619,185 L.L
L01EA01	GLIMATINIB BENTA	G	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	43,103,200 L.L
L01EA01	GLIMATINIB BENTA 400	G	Imatinib (mesylate) - 400mg	400mg	Tablet, film coated	L.L
L01BC05	GEMCITABINE THYMOORGAN	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	L.L
L01BC05	GEMTABINE 1000	G	Gemcitabine HCl - 1,000mg	1,000mg	Injectable lyophilised powder for solution	L.L
L01BC05	GEMCITABIN EBEWE	G	Gemcitabine (HCl) - 200mg/20ml	200mg/20ml	Injectable concentrated solution	2,121,927 L.L
L01BC05	GEMCITABINE NEAPOLIS	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,490,321 L.L
L01BC05	GEMCITABINE THYMOORGAN	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,617,986 L.L
L01BC05	GEMNIL	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,128,828 L.L
L01BC05	GEMTABINE 200	G	Gemcitabine HCl - 200mg	200mg	Injectable lyophilised powder for solution	1,343,843 L.L
L01BC05	GEMCI-CELL	G	Gemcitabine (HCl) - 1g/Vial	1g/Vial	Injectable concentrate for solution	9,326,123 L.L
L01BC05	GEMCITABIN EBEWE	G	Gemcitabine (HCl) - 1g/100ml	1g/100ml	Injectable concentrated solution	7,512,674 L.L
L01BC05	GEMCITABINE NEAPOLIS	G	Gemcitabine (HCl) - 1000mg	1000mg	Injectable powder for solution	4,942,653 L.L
L01BC05	GEMCITABINE THYMOORGAN	G	Gemcitabine (HCl) - 1g	1g	Injectable powder for solution	5,843,027 L.L
L01BC05	GEMNIL	G	Gemcitabine (HCl) - 1g	1g	Injectable powder for solution	3,369,013 L.L
L01BC05	GEMTABINE 1000	G	Gemcitabine HCl - 1,000mg	1,000mg	Injectable lyophilised powder for solution	4,882,628 L.L
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml		Injectable suspension	14,139,396 L.L
J07BB01	GC FLU QUADRIVALENT INFLUENZA VACCINE	G	Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml		Injectable suspension	791,523 L.L
J06BA02	GAMUNEX-C	BioHuman	Human normal immunoglobulin G - 10%	10%	Injectable solution	39,990,287 L.L
J05AR18	GENVOYA	B	Emtricitabine - 200mg, Tenofovir alafenamide - 10mg, Elvitegravir - 150mg, Cobicistat - 150mg		Tablet, film coated	77,789,650 L.L